Cigna earnings beat by $0.04, revenue topped estimates
SAINT PAUL, MINNESOTA - Quasar Medical (TASE:BLWV), known for manufacturing interventional and minimally invasive medical devices, has entered into a definitive agreement to acquire Nordson Corporation’s (NASDAQ:NDSN) design and development contract manufacturing businesses located in Galway, Ireland, and Tecate, Mexico. This strategic move is set to enhance Quasar’s capabilities as a full-service Contract Development and Manufacturing Organization (CDMO), offering a complete range of services from initial design to large-scale production.
The acquisition, expected to be finalized in the third quarter of 2025, will integrate the Galway and Tecate facilities into Quasar’s global network, adding 800,000 square feet of manufacturing space and more than 4,200 employees, including over 50 New Product Development (NPD) Engineers. These sites are not only equipped with FDA-registered and ISO 13485 certified operations but also bring a workforce skilled in complex balloon and catheter design, rapid prototyping, and cost-efficient device assembly.
Quasar’s CEO, Alex Wallstein, emphasized the significance of the acquisition, stating it is set to diversify the company into a global CDMO partner. The integration of the Galway and Tecate sites will provide Quasar with a broader range of expertise and facilities, bolstering its position in the medical device sector.
Customers of Quasar Medical can anticipate benefits such as integrated design-for-manufacturing, scalable production capabilities, faster time to market, and regionally optimized manufacturing strategies. The acquisition aims to offer a robust quality infrastructure and seamless program transfers to ensure market readiness.
Quasar Medical plans to work closely with Nordson to facilitate a smooth transition for all customers and suppliers. Once the deal is closed, the Galway and Tecate sites will be fully integrated into Quasar’s platform.
With 10 global facilities, Quasar Medical is headquartered in Singapore and operates under ISO 13485:2016 and cGMP standards. The company serves leading medical device OEMs and innovators worldwide, specializing in catheter systems, balloon technologies, micro-EM sensors, and complex assemblies.
Nordson MEDICAL, recognized for its expertise in medical component technologies, is refining its focus on its core components business following the divestiture.
This article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.